Back to VANGUARD GROUP INC VANGUARD GROUP INC

XERSXERS
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in XERIS BIOPHARMA HOLDINGS INC

VANGUARD GROUP INC holds 11.2M shares of XERS (XERIS BIOPHARMA HOLDINGS INC), worth $87.8M as of 2025-Q4. The position was increased (+13.8% shares). XERS represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$87.8M

Current Shares

11.2M

Total Value Change

+$65.7M

Total Shares Change

+3.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
11.2M
+13.8%
$87.8M0.0%$7.31
34
2025-Q3
Increased
9.8M
+0.1%
$80M0.0%$8.08
30
2025-Q2
Increased
9.8M
+21.1%
$45.8M0.0%$4.70
35
2025-Q1
Increased
8.1M
+2.7%
$44.5M0.0%$5.58
30
2024-Q4
Increased
7.9M
+1.7%
$26.8M0.0%$3.38
29
2024-Q3
New
7.8M
-
$22.1M0.0%$2.87
39

Other major holders of XERS: BlackRock, Inc., D. E. Shaw & Co., Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used